Caliper Q2 Revenues Bounce 32 Percent on Strong Research Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Driven by its Research business, Califer Life Sciences reported after the close of the market on Tuesday a 32 percent year-over-year increase in revenues for the second quarter.

For the three months ended June 30, total revenues climbed to $38.3 million, up from $29.1 million a year ago. Organically, revenues grew 23 percent year over year, the company said.

Wall Street had expected $34.4 million in total revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.